

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neuron cell-cell adhesion (GO:0007158) | 5.83660586 |
| 2 | vocalization behavior (GO:0071625) | 5.54996332 |
| 3 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.15771494 |
| 4 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.96226754 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.93240002 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 4.90912404 |
| 7 | protein localization to synapse (GO:0035418) | 4.82497015 |
| 8 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.78876234 |
| 9 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.62921084 |
| 10 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.59443140 |
| 11 | presynaptic membrane assembly (GO:0097105) | 4.55551006 |
| 12 | postsynaptic membrane organization (GO:0001941) | 4.52671612 |
| 13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.49467770 |
| 14 | synaptic vesicle maturation (GO:0016188) | 4.48499499 |
| 15 | glutamate secretion (GO:0014047) | 4.43229451 |
| 16 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.34347219 |
| 17 | locomotory exploration behavior (GO:0035641) | 4.20603538 |
| 18 | negative regulation of cell killing (GO:0031342) | 4.14617849 |
| 19 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.14617849 |
| 20 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.10210221 |
| 21 | layer formation in cerebral cortex (GO:0021819) | 4.04373666 |
| 22 | presynaptic membrane organization (GO:0097090) | 4.04085633 |
| 23 | neuron recognition (GO:0008038) | 4.01803539 |
| 24 | regulation of synaptic vesicle transport (GO:1902803) | 4.01368285 |
| 25 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.93605512 |
| 26 | exploration behavior (GO:0035640) | 3.88944313 |
| 27 | dendritic spine morphogenesis (GO:0060997) | 3.87110240 |
| 28 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.73746722 |
| 29 | neurotransmitter secretion (GO:0007269) | 3.70737429 |
| 30 | glutamate receptor signaling pathway (GO:0007215) | 3.67831688 |
| 31 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.66934678 |
| 32 | proline transport (GO:0015824) | 3.58587484 |
| 33 | axonal fasciculation (GO:0007413) | 3.54969795 |
| 34 | innervation (GO:0060384) | 3.54549873 |
| 35 | nucleobase catabolic process (GO:0046113) | 3.53662067 |
| 36 | neuron-neuron synaptic transmission (GO:0007270) | 3.49616387 |
| 37 | synaptic transmission, glutamatergic (GO:0035249) | 3.47830409 |
| 38 | startle response (GO:0001964) | 3.47731628 |
| 39 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.47635391 |
| 40 | dendrite morphogenesis (GO:0048813) | 3.45458647 |
| 41 | positive regulation of membrane potential (GO:0045838) | 3.44723385 |
| 42 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.44235803 |
| 43 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.41950226 |
| 44 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.41634355 |
| 45 | positive regulation of synapse maturation (GO:0090129) | 3.40710779 |
| 46 | long-term synaptic potentiation (GO:0060291) | 3.37900246 |
| 47 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.37010150 |
| 48 | detection of molecule of bacterial origin (GO:0032490) | 3.36492051 |
| 49 | regulation of vesicle fusion (GO:0031338) | 3.36284403 |
| 50 | microglial cell activation (GO:0001774) | 3.33470824 |
| 51 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.32096434 |
| 52 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.30946212 |
| 53 | response to histamine (GO:0034776) | 3.26522948 |
| 54 | activation of protein kinase A activity (GO:0034199) | 3.26351282 |
| 55 | synaptic vesicle endocytosis (GO:0048488) | 3.25966138 |
| 56 | regulation of synapse structural plasticity (GO:0051823) | 3.23085288 |
| 57 | positive regulation of synapse assembly (GO:0051965) | 3.23014742 |
| 58 | regulation of postsynaptic membrane potential (GO:0060078) | 3.22125700 |
| 59 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.18171106 |
| 60 | response to pheromone (GO:0019236) | 3.15357329 |
| 61 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.15025432 |
| 62 | detection of calcium ion (GO:0005513) | 3.14621250 |
| 63 | synapse assembly (GO:0007416) | 3.13207673 |
| 64 | striatum development (GO:0021756) | 3.13032075 |
| 65 | oxygen transport (GO:0015671) | 3.06653145 |
| 66 | cochlea development (GO:0090102) | 3.05739376 |
| 67 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.04572896 |
| 68 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.04329033 |
| 69 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.04064398 |
| 70 | neurotransmitter transport (GO:0006836) | 3.04054280 |
| 71 | cerebellar granule cell differentiation (GO:0021707) | 3.04033880 |
| 72 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.03701767 |
| 73 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.03098868 |
| 74 | long-term memory (GO:0007616) | 3.02998262 |
| 75 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.02407119 |
| 76 | regulation of beta-amyloid formation (GO:1902003) | 3.01775757 |
| 77 | neuronal action potential propagation (GO:0019227) | 3.00207389 |
| 78 | neutrophil mediated immunity (GO:0002446) | 2.99840516 |
| 79 | positive regulation by symbiont of host defense response (GO:0052509) | 2.99266648 |
| 80 | modulation by symbiont of host defense response (GO:0052031) | 2.99266648 |
| 81 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.99266648 |
| 82 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.99266648 |
| 83 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.99266648 |
| 84 | modulation by symbiont of host immune response (GO:0052553) | 2.99266648 |
| 85 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.98323636 |
| 86 | calcium ion-dependent exocytosis (GO:0017156) | 2.98203450 |
| 87 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.97513627 |
| 88 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.96055634 |
| 89 | hemoglobin metabolic process (GO:0020027) | 2.95244144 |
| 90 | dendrite development (GO:0016358) | 2.94730446 |
| 91 | macrophage activation involved in immune response (GO:0002281) | 2.94587424 |
| 92 | positive regulation of fibroblast migration (GO:0010763) | 2.94339561 |
| 93 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.94254129 |
| 94 | cell migration in hindbrain (GO:0021535) | 2.93132242 |
| 95 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.92588770 |
| 96 | regulation of synaptic plasticity (GO:0048167) | 2.92582318 |
| 97 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.92132056 |
| 98 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.91714465 |
| 99 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.91641429 |
| 100 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.91240087 |
| 101 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.90111749 |
| 102 | auditory behavior (GO:0031223) | 2.89296046 |
| 103 | activated T cell proliferation (GO:0050798) | 2.88715842 |
| 104 | gamma-aminobutyric acid transport (GO:0015812) | 2.87267213 |
| 105 | regulation of neurotransmitter secretion (GO:0046928) | 2.86538848 |
| 106 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.86257862 |
| 107 | dopamine biosynthetic process (GO:0042416) | 2.85967820 |
| 108 | intraspecies interaction between organisms (GO:0051703) | 2.82580933 |
| 109 | social behavior (GO:0035176) | 2.82580933 |
| 110 | transmission of nerve impulse (GO:0019226) | 2.80778588 |
| 111 | response to methylmercury (GO:0051597) | 2.80580091 |
| 112 | cellular response to epinephrine stimulus (GO:0071872) | 2.80499510 |
| 113 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.78718189 |
| 114 | behavioral defense response (GO:0002209) | 2.78114776 |
| 115 | behavioral fear response (GO:0001662) | 2.78114776 |
| 116 | regulation of synapse assembly (GO:0051963) | 2.78045887 |
| 117 | organelle transport along microtubule (GO:0072384) | 2.76774603 |
| 118 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.76552119 |
| 119 | membrane depolarization (GO:0051899) | 2.76144474 |
| 120 | learning (GO:0007612) | 2.75467370 |
| 121 | righting reflex (GO:0060013) | 2.75310008 |
| 122 | clathrin coat assembly (GO:0048268) | 2.74848452 |
| 123 | vesicle transport along microtubule (GO:0047496) | 2.74508689 |
| 124 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.74250550 |
| 125 | myeloid leukocyte mediated immunity (GO:0002444) | 2.74205004 |
| 126 | synapse organization (GO:0050808) | 2.74030020 |
| 127 | axon extension (GO:0048675) | 2.72828133 |
| 128 | regulation of synapse maturation (GO:0090128) | 2.72557335 |
| 129 | fear response (GO:0042596) | 2.71236036 |
| 130 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.70351039 |
| 131 | regulation of neurotransmitter levels (GO:0001505) | 2.70236293 |
| 132 | cellular extravasation (GO:0045123) | 2.66935039 |
| 133 | erythrocyte development (GO:0048821) | 2.65908994 |
| 134 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.63692006 |
| 135 | gas transport (GO:0015669) | 2.62463562 |
| 136 | detection of external biotic stimulus (GO:0098581) | 2.59365399 |
| 137 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.57950433 |
| 138 | macrophage activation (GO:0042116) | 2.56944597 |
| 139 | detection of other organism (GO:0098543) | 2.56407736 |
| 140 | negative regulation of neurotransmitter transport (GO:0051589) | 2.55016776 |
| 141 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.53984313 |
| 142 | positive regulation of neurotransmitter transport (GO:0051590) | 2.52516988 |
| 143 | protein targeting to Golgi (GO:0000042) | 2.51831568 |
| 144 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.50443105 |
| 145 | negative regulation of T cell mediated immunity (GO:0002710) | 2.50245449 |
| 146 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.48749740 |
| 147 | response to peptidoglycan (GO:0032494) | 2.45883620 |
| 148 | positive regulation of Rap GTPase activity (GO:0032854) | 2.44501173 |
| 149 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.43474349 |
| 150 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.42369355 |
| 151 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.42369355 |
| 152 | glycine transport (GO:0015816) | 2.40983063 |
| 153 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.39297164 |
| 154 | regulation of cellular amide metabolic process (GO:0034248) | 2.38718376 |
| 155 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.38618618 |
| 156 | establishment of protein localization to Golgi (GO:0072600) | 2.38578972 |
| 157 | response to epinephrine (GO:0071871) | 2.38016648 |
| 158 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.36104894 |
| 159 | negative regulation of interleukin-12 production (GO:0032695) | 2.35832839 |
| 160 | L-amino acid import (GO:0043092) | 2.33618128 |
| 161 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.31590183 |
| 162 | regulation of platelet aggregation (GO:0090330) | 2.31503622 |
| 163 | regulation of Rap GTPase activity (GO:0032317) | 2.29831307 |
| 164 | positive regulation of granulocyte differentiation (GO:0030854) | 2.29049429 |
| 165 | response to host immune response (GO:0052572) | 2.28853683 |
| 166 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.28853683 |
| 167 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.28192847 |
| 168 | negative regulation of type 2 immune response (GO:0002829) | 2.26439003 |
| 169 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 2.25159344 |
| 170 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.23938561 |
| 171 | regulation of gamma-delta T cell activation (GO:0046643) | 2.23631712 |
| 172 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.22912065 |
| 173 | regulation of ARF protein signal transduction (GO:0032012) | 2.22867292 |
| 174 | myeloid cell development (GO:0061515) | 2.19879626 |
| 175 | detection of bacterium (GO:0016045) | 2.19145819 |
| 176 | detection of biotic stimulus (GO:0009595) | 2.17310969 |
| 177 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.16919164 |
| 178 | leukocyte aggregation (GO:0070486) | 2.16107168 |
| 179 | neutrophil activation involved in immune response (GO:0002283) | 2.15809323 |
| 180 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.13737380 |
| 181 | regulation of cell maturation (GO:1903429) | 2.11658071 |
| 182 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.11415131 |
| 183 | cellular response to monoamine stimulus (GO:0071868) | 2.09424009 |
| 184 | cellular response to catecholamine stimulus (GO:0071870) | 2.09424009 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.45914209 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.02619995 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.08266638 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.59462797 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.52685871 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.51101321 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.46716775 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.40847962 |
| 9 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.38507341 |
| 10 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.34920796 |
| 11 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.33854091 |
| 12 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.27592680 |
| 13 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.26493642 |
| 14 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.23463361 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.22454263 |
| 16 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.19202592 |
| 17 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.16296797 |
| 18 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.13025321 |
| 19 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.10784001 |
| 20 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.08982245 |
| 21 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.06500966 |
| 22 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.06168928 |
| 23 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.04207959 |
| 24 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.02073639 |
| 25 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.02073639 |
| 26 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.01384872 |
| 27 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.99497124 |
| 28 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.97087365 |
| 29 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.94252988 |
| 30 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.86201469 |
| 31 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.85963535 |
| 32 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.85502295 |
| 33 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.84618681 |
| 34 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.84503749 |
| 35 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.83306692 |
| 36 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.83004904 |
| 37 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.82153388 |
| 38 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.80109821 |
| 39 | P300_19829295_ChIP-Seq_ESCs_Human | 1.78589955 |
| 40 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.78141323 |
| 41 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.73742658 |
| 42 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.72762376 |
| 43 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.69322289 |
| 44 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.68657132 |
| 45 | FUS_26573619_Chip-Seq_HEK293_Human | 1.64381519 |
| 46 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.64174602 |
| 47 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.61995185 |
| 48 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.60808305 |
| 49 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.59565186 |
| 50 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.58838399 |
| 51 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.58312242 |
| 52 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.57248219 |
| 53 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.54620606 |
| 54 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.53294936 |
| 55 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53203968 |
| 56 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.53099268 |
| 57 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.51754663 |
| 58 | AR_25329375_ChIP-Seq_VCAP_Human | 1.50448069 |
| 59 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.49451451 |
| 60 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.48744657 |
| 61 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.48515697 |
| 62 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.48008115 |
| 63 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.47116533 |
| 64 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.46836630 |
| 65 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.44344616 |
| 66 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.41464698 |
| 67 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.41453009 |
| 68 | TP53_16413492_ChIP-PET_HCT116_Human | 1.40202187 |
| 69 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.40141947 |
| 70 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.38363744 |
| 71 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38355796 |
| 72 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.33652832 |
| 73 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.32701735 |
| 74 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32155791 |
| 75 | GATA1_19941826_ChIP-Seq_K562_Human | 1.29254249 |
| 76 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28746092 |
| 77 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.28416881 |
| 78 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.27419974 |
| 79 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.26835683 |
| 80 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.25914685 |
| 81 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.25603494 |
| 82 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.23005228 |
| 83 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23005228 |
| 84 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.22929107 |
| 85 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.22302133 |
| 86 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.22105605 |
| 87 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.21600078 |
| 88 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.21482896 |
| 89 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.21105419 |
| 90 | VDR_22108803_ChIP-Seq_LS180_Human | 1.19916728 |
| 91 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.19905625 |
| 92 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.19864117 |
| 93 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.18896267 |
| 94 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.18852333 |
| 95 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18782554 |
| 96 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.17861370 |
| 97 | GATA1_22025678_ChIP-Seq_K562_Human | 1.16085813 |
| 98 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.15765163 |
| 99 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.15616284 |
| 100 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14017531 |
| 101 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.13609913 |
| 102 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.13309239 |
| 103 | AR_19668381_ChIP-Seq_PC3_Human | 1.10865283 |
| 104 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10275429 |
| 105 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.10040968 |
| 106 | JUN_21703547_ChIP-Seq_K562_Human | 1.10029329 |
| 107 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.09997929 |
| 108 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.09997929 |
| 109 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.09224617 |
| 110 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.09153976 |
| 111 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.08969504 |
| 112 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.08832391 |
| 113 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.08720968 |
| 114 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.07599838 |
| 115 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.06672388 |
| 116 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05629017 |
| 117 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.05342887 |
| 118 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.05113663 |
| 119 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.05047653 |
| 120 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.04161899 |
| 121 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.03909105 |
| 122 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03429936 |
| 123 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.01832664 |
| 124 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.01230151 |
| 125 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.00977469 |
| 126 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00224423 |
| 127 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.00069965 |
| 128 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.99609476 |
| 129 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.98851019 |
| 130 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.98046437 |
| 131 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97048302 |
| 132 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96430343 |
| 133 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.96074253 |
| 134 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95668416 |
| 135 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.95358896 |
| 136 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.94767273 |
| 137 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.94341251 |
| 138 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.93786573 |
| 139 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.93666872 |
| 140 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.93087079 |
| 141 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.92744670 |
| 142 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92536136 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.94458812 |
| 2 | MP0003880_abnormal_central_pattern | 4.35611668 |
| 3 | MP0004270_analgesia | 3.85187453 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.70717772 |
| 5 | MP0003656_abnormal_erythrocyte_physiolo | 3.51396980 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.07964516 |
| 7 | MP0003724_increased_susceptibility_to | 3.03830888 |
| 8 | MP0009745_abnormal_behavioral_response | 2.98019376 |
| 9 | MP0008260_abnormal_autophagy | 2.84909590 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.78303023 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.73828891 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.69866148 |
| 13 | MP0009046_muscle_twitch | 2.59605999 |
| 14 | MP0002064_seizures | 2.59501377 |
| 15 | MP0003303_peritoneal_inflammation | 2.52116362 |
| 16 | MP0005423_abnormal_somatic_nervous | 2.42919431 |
| 17 | MP0000778_abnormal_nervous_system | 2.41658321 |
| 18 | MP0006082_CNS_inflammation | 2.39626573 |
| 19 | MP0009780_abnormal_chondrocyte_physiolo | 2.28419235 |
| 20 | MP0002735_abnormal_chemical_nociception | 2.25120987 |
| 21 | MP0003172_abnormal_lysosome_physiology | 2.17751793 |
| 22 | MP0002736_abnormal_nociception_after | 2.17192844 |
| 23 | MP0001440_abnormal_grooming_behavior | 2.16651972 |
| 24 | MP0000569_abnormal_digit_pigmentation | 2.14910971 |
| 25 | MP0006276_abnormal_autonomic_nervous | 2.14308985 |
| 26 | MP0002184_abnormal_innervation | 2.14203964 |
| 27 | MP0003122_maternal_imprinting | 2.12292116 |
| 28 | MP0003787_abnormal_imprinting | 2.09354163 |
| 29 | MP0001486_abnormal_startle_reflex | 2.06537219 |
| 30 | MP0002272_abnormal_nervous_system | 2.05762260 |
| 31 | MP0005646_abnormal_pituitary_gland | 2.04693788 |
| 32 | MP0004510_myositis | 2.04577761 |
| 33 | MP0001529_abnormal_vocalization | 2.03374809 |
| 34 | MP0002733_abnormal_thermal_nociception | 2.02824175 |
| 35 | MP0001984_abnormal_olfaction | 1.99389537 |
| 36 | MP0003690_abnormal_glial_cell | 1.95673234 |
| 37 | MP0002067_abnormal_sensory_capabilities | 1.85047126 |
| 38 | MP0001501_abnormal_sleep_pattern | 1.82031764 |
| 39 | MP0004924_abnormal_behavior | 1.81957406 |
| 40 | MP0005386_behavior/neurological_phenoty | 1.81957406 |
| 41 | MP0001970_abnormal_pain_threshold | 1.81050508 |
| 42 | MP0002557_abnormal_social/conspecific_i | 1.80513547 |
| 43 | MP0002822_catalepsy | 1.79296606 |
| 44 | MP0002837_dystrophic_cardiac_calcinosis | 1.68833785 |
| 45 | MP0004147_increased_porphyrin_level | 1.68035825 |
| 46 | MP0004811_abnormal_neuron_physiology | 1.67275108 |
| 47 | MP0002909_abnormal_adrenal_gland | 1.65723654 |
| 48 | MP0001188_hyperpigmentation | 1.59130821 |
| 49 | MP0006292_abnormal_olfactory_placode | 1.52880872 |
| 50 | MP0009785_altered_susceptibility_to | 1.52818811 |
| 51 | MP0000955_abnormal_spinal_cord | 1.51428763 |
| 52 | MP0003879_abnormal_hair_cell | 1.51406447 |
| 53 | MP0001905_abnormal_dopamine_level | 1.50626668 |
| 54 | MP0002332_abnormal_exercise_endurance | 1.48321633 |
| 55 | MP0001835_abnormal_antigen_presentation | 1.47384400 |
| 56 | MP0000013_abnormal_adipose_tissue | 1.46584062 |
| 57 | MP0002419_abnormal_innate_immunity | 1.44735976 |
| 58 | MP0004883_abnormal_blood_vessel | 1.43640308 |
| 59 | MP0005645_abnormal_hypothalamus_physiol | 1.42228243 |
| 60 | MP0003329_amyloid_beta_deposits | 1.41709051 |
| 61 | MP0010386_abnormal_urinary_bladder | 1.40254391 |
| 62 | MP0001986_abnormal_taste_sensitivity | 1.36773319 |
| 63 | MP0002882_abnormal_neuron_morphology | 1.35905758 |
| 64 | MP0001958_emphysema | 1.33119119 |
| 65 | MP0003436_decreased_susceptibility_to | 1.31545816 |
| 66 | MP0003300_gastrointestinal_ulcer | 1.30972792 |
| 67 | MP0002066_abnormal_motor_capabilities/c | 1.27288127 |
| 68 | MP0008569_lethality_at_weaning | 1.24578400 |
| 69 | MP0001502_abnormal_circadian_rhythm | 1.23904646 |
| 70 | MP0008877_abnormal_DNA_methylation | 1.23395558 |
| 71 | MP0000631_abnormal_neuroendocrine_gland | 1.22866702 |
| 72 | MP0008438_abnormal_cutaneous_collagen | 1.20125389 |
| 73 | MP0004484_altered_response_of | 1.18180301 |
| 74 | MP0002152_abnormal_brain_morphology | 1.16380490 |
| 75 | MP0003195_calcinosis | 1.16339352 |
| 76 | MP0008874_decreased_physiological_sensi | 1.12758248 |
| 77 | MP0005503_abnormal_tendon_morphology | 1.11947008 |
| 78 | MP0002102_abnormal_ear_morphology | 1.11761203 |
| 79 | MP0002638_abnormal_pupillary_reflex | 1.11500494 |
| 80 | MP0003121_genomic_imprinting | 1.10057701 |
| 81 | MP0005164_abnormal_response_to | 1.08374849 |
| 82 | MP0005000_abnormal_immune_tolerance | 1.07745519 |
| 83 | MP0004858_abnormal_nervous_system | 1.07482082 |
| 84 | MP0000685_abnormal_immune_system | 1.07454397 |
| 85 | MP0003191_abnormal_cellular_cholesterol | 1.06785937 |
| 86 | MP0005410_abnormal_fertilization | 1.05968872 |
| 87 | MP0000920_abnormal_myelination | 1.05958536 |
| 88 | MP0005025_abnormal_response_to | 1.04742049 |
| 89 | MP0002876_abnormal_thyroid_physiology | 1.03826624 |
| 90 | MP0003828_pulmonary_edema | 1.03793619 |
| 91 | MP0001800_abnormal_humoral_immune | 1.03199707 |
| 92 | MP0001790_abnormal_immune_system | 1.02178287 |
| 93 | MP0005387_immune_system_phenotype | 1.02178287 |
| 94 | MP0003183_abnormal_peptide_metabolism | 0.99653794 |
| 95 | MP0005499_abnormal_olfactory_system | 0.97551472 |
| 96 | MP0005394_taste/olfaction_phenotype | 0.97551472 |
| 97 | MP0001542_abnormal_bone_strength | 0.97490891 |
| 98 | MP0004142_abnormal_muscle_tone | 0.97317677 |
| 99 | MP0003045_fibrosis | 0.96914209 |
| 100 | MP0002420_abnormal_adaptive_immunity | 0.96177342 |
| 101 | MP0001533_abnormal_skeleton_physiology | 0.95401832 |
| 102 | MP0002723_abnormal_immune_serum | 0.95028217 |
| 103 | MP0004130_abnormal_muscle_cell | 0.94376215 |
| 104 | MP0006072_abnormal_retinal_apoptosis | 0.92970953 |
| 105 | MP0003091_abnormal_cell_migration | 0.92819437 |
| 106 | MP0005174_abnormal_tail_pigmentation | 0.91812669 |
| 107 | MP0008004_abnormal_stomach_pH | 0.91772696 |
| 108 | MP0001819_abnormal_immune_cell | 0.91710708 |
| 109 | MP0004085_abnormal_heartbeat | 0.91243573 |
| 110 | MP0002928_abnormal_bile_duct | 0.90188485 |
| 111 | MP0004742_abnormal_vestibular_system | 0.88944550 |
| 112 | MP0004885_abnormal_endolymph | 0.87147350 |
| 113 | MP0005379_endocrine/exocrine_gland_phen | 0.86527694 |
| 114 | MP0002069_abnormal_eating/drinking_beha | 0.85832781 |
| 115 | MP0002653_abnormal_ependyma_morphology | 0.85627268 |
| 116 | MP0005535_abnormal_body_temperature | 0.84512067 |
| 117 | MP0000604_amyloidosis | 0.83058472 |
| 118 | MP0005671_abnormal_response_to | 0.82935492 |
| 119 | MP0002752_abnormal_somatic_nervous | 0.82251699 |
| 120 | MP0003631_nervous_system_phenotype | 0.81032248 |
| 121 | MP0002452_abnormal_antigen_presenting | 0.80703680 |
| 122 | MP0003646_muscle_fatigue | 0.80611235 |
| 123 | MP0005551_abnormal_eye_electrophysiolog | 0.80366308 |
| 124 | MP0002751_abnormal_autonomic_nervous | 0.79890460 |
| 125 | MP0003633_abnormal_nervous_system | 0.79118131 |
| 126 | MP0002295_abnormal_pulmonary_circulatio | 0.78951800 |
| 127 | MP0000751_myopathy | 0.78753753 |
| 128 | MP0005075_abnormal_melanosome_morpholog | 0.78455818 |
| 129 | MP0001963_abnormal_hearing_physiology | 0.78226535 |
| 130 | MP0005310_abnormal_salivary_gland | 0.78116649 |
| 131 | MP0003861_abnormal_nervous_system | 0.76864792 |
| 132 | MP0002405_respiratory_system_inflammati | 0.75917540 |
| 133 | MP0002229_neurodegeneration | 0.75747983 |
| 134 | MP0003698_abnormal_male_reproductive | 0.74915918 |
| 135 | MP0004233_abnormal_muscle_weight | 0.74775398 |
| 136 | MP0002998_abnormal_bone_remodeling | 0.74199935 |
| 137 | MP0008789_abnormal_olfactory_epithelium | 0.71785971 |
| 138 | MP0003632_abnormal_nervous_system | 0.70680483 |
| 139 | MP0005187_abnormal_penis_morphology | 0.70335689 |
| 140 | MP0003119_abnormal_digestive_system | 0.68786751 |
| 141 | MP0003634_abnormal_glial_cell | 0.67523310 |
| 142 | MP0004145_abnormal_muscle_electrophysio | 0.67466687 |
| 143 | MP0005248_abnormal_Harderian_gland | 0.65531666 |
| 144 | MP0000015_abnormal_ear_pigmentation | 0.63705798 |
| 145 | MP0001299_abnormal_eye_distance/ | 0.60850158 |
| 146 | MP0002693_abnormal_pancreas_physiology | 0.58474462 |
| 147 | MP0002090_abnormal_vision | 0.58260002 |
| 148 | MP0000026_abnormal_inner_ear | 0.57870015 |
| 149 | MP0004215_abnormal_myocardial_fiber | 0.57515495 |
| 150 | MP0003123_paternal_imprinting | 0.57455104 |
| 151 | MP0001664_abnormal_digestion | 0.56867466 |
| 152 | MP0001943_abnormal_respiration | 0.55871859 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.60285092 |
| 2 | Hypochromic microcytic anemia (HP:0004840) | 5.37808965 |
| 3 | Visual hallucinations (HP:0002367) | 4.70244866 |
| 4 | Myokymia (HP:0002411) | 4.67291367 |
| 5 | Focal seizures (HP:0007359) | 4.53193254 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.51496687 |
| 7 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.30917047 |
| 8 | Atonic seizures (HP:0010819) | 4.26880971 |
| 9 | Hyperventilation (HP:0002883) | 4.22196256 |
| 10 | Febrile seizures (HP:0002373) | 3.81462791 |
| 11 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.72128544 |
| 12 | Progressive cerebellar ataxia (HP:0002073) | 3.71158963 |
| 13 | Absence seizures (HP:0002121) | 3.67920452 |
| 14 | Microcytic anemia (HP:0001935) | 3.57833814 |
| 15 | Recurrent bacterial skin infections (HP:0005406) | 3.41528319 |
| 16 | Stomatitis (HP:0010280) | 3.38812673 |
| 17 | Postural instability (HP:0002172) | 3.35358759 |
| 18 | Broad-based gait (HP:0002136) | 3.34415926 |
| 19 | Dialeptic seizures (HP:0011146) | 3.27191358 |
| 20 | Generalized tonic-clonic seizures (HP:0002069) | 3.21467025 |
| 21 | Drooling (HP:0002307) | 3.19959882 |
| 22 | Excessive salivation (HP:0003781) | 3.19959882 |
| 23 | Polyphagia (HP:0002591) | 3.16998639 |
| 24 | Epileptiform EEG discharges (HP:0011182) | 3.06021069 |
| 25 | Peritonitis (HP:0002586) | 2.99765298 |
| 26 | Recurrent abscess formation (HP:0002722) | 2.99461249 |
| 27 | Poikilocytosis (HP:0004447) | 2.98313380 |
| 28 | Mutism (HP:0002300) | 2.95655107 |
| 29 | Limb dystonia (HP:0002451) | 2.94782449 |
| 30 | EEG with generalized epileptiform discharges (HP:0011198) | 2.94286898 |
| 31 | Optic neuritis (HP:0100653) | 2.91314979 |
| 32 | Retrobulbar optic neuritis (HP:0100654) | 2.91314979 |
| 33 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.87962399 |
| 34 | Hypsarrhythmia (HP:0002521) | 2.82266724 |
| 35 | Amblyopia (HP:0000646) | 2.81651663 |
| 36 | Hypochromic anemia (HP:0001931) | 2.80943406 |
| 37 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.78797545 |
| 38 | Eczematoid dermatitis (HP:0000976) | 2.78373988 |
| 39 | Agitation (HP:0000713) | 2.75788658 |
| 40 | Gait imbalance (HP:0002141) | 2.75108369 |
| 41 | Orchitis (HP:0100796) | 2.74213825 |
| 42 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.73152446 |
| 43 | Absent/shortened dynein arms (HP:0200106) | 2.73152446 |
| 44 | Toxemia of pregnancy (HP:0100603) | 2.72486037 |
| 45 | Hematochezia (HP:0002573) | 2.70973070 |
| 46 | Myositis (HP:0100614) | 2.70114867 |
| 47 | Abnormal eating behavior (HP:0100738) | 2.68959242 |
| 48 | Abnormality of macrophages (HP:0004311) | 2.67433846 |
| 49 | Amyotrophic lateral sclerosis (HP:0007354) | 2.63497474 |
| 50 | Ankle clonus (HP:0011448) | 2.59677431 |
| 51 | Increased circulating renin level (HP:0000848) | 2.59200942 |
| 52 | Papilledema (HP:0001085) | 2.58327703 |
| 53 | Absent speech (HP:0001344) | 2.56529487 |
| 54 | Progressive inability to walk (HP:0002505) | 2.55639604 |
| 55 | Supranuclear gaze palsy (HP:0000605) | 2.55132666 |
| 56 | Pheochromocytoma (HP:0002666) | 2.52724458 |
| 57 | Gastrointestinal infarctions (HP:0005244) | 2.52666003 |
| 58 | Poor eye contact (HP:0000817) | 2.52593255 |
| 59 | Spontaneous hematomas (HP:0007420) | 2.48113208 |
| 60 | Papillary thyroid carcinoma (HP:0002895) | 2.46191245 |
| 61 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.46174550 |
| 62 | Anxiety (HP:0000739) | 2.45963753 |
| 63 | Protruding tongue (HP:0010808) | 2.44456957 |
| 64 | Resting tremor (HP:0002322) | 2.43460872 |
| 65 | Fetal akinesia sequence (HP:0001989) | 2.43411611 |
| 66 | Slow saccadic eye movements (HP:0000514) | 2.43226805 |
| 67 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.42583107 |
| 68 | T lymphocytopenia (HP:0005403) | 2.41529355 |
| 69 | Blue irides (HP:0000635) | 2.39855594 |
| 70 | Truncal ataxia (HP:0002078) | 2.39268761 |
| 71 | Bradykinesia (HP:0002067) | 2.39226875 |
| 72 | Abnormal hair whorl (HP:0010721) | 2.36865242 |
| 73 | Abnormality of the labia minora (HP:0012880) | 2.36538581 |
| 74 | Poor suck (HP:0002033) | 2.34570046 |
| 75 | Genetic anticipation (HP:0003743) | 2.32449755 |
| 76 | Akinesia (HP:0002304) | 2.31756644 |
| 77 | Episodic fever (HP:0001954) | 2.31236960 |
| 78 | Inability to walk (HP:0002540) | 2.30127387 |
| 79 | Gaze-evoked nystagmus (HP:0000640) | 2.29203215 |
| 80 | Depression (HP:0000716) | 2.28015645 |
| 81 | Ventricular fibrillation (HP:0001663) | 2.27839090 |
| 82 | Medial flaring of the eyebrow (HP:0010747) | 2.26856715 |
| 83 | Hemiplegia (HP:0002301) | 2.26679382 |
| 84 | Abnormality of T cell number (HP:0011839) | 2.25281135 |
| 85 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.23460189 |
| 86 | Facial hemangioma (HP:0000329) | 2.23013911 |
| 87 | Intention tremor (HP:0002080) | 2.22000109 |
| 88 | Striae distensae (HP:0001065) | 2.20820884 |
| 89 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.20045495 |
| 90 | Gingival bleeding (HP:0000225) | 2.19575204 |
| 91 | Abnormal social behavior (HP:0012433) | 2.19155055 |
| 92 | Impaired social interactions (HP:0000735) | 2.19155055 |
| 93 | Insidious onset (HP:0003587) | 2.18414331 |
| 94 | Termporal pattern (HP:0011008) | 2.18414331 |
| 95 | Rigidity (HP:0002063) | 2.18273081 |
| 96 | Abnormality of the corticospinal tract (HP:0002492) | 2.17127607 |
| 97 | Cerebral inclusion bodies (HP:0100314) | 2.16446423 |
| 98 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.15607675 |
| 99 | Abnormality of salivation (HP:0100755) | 2.13954157 |
| 100 | Inappropriate behavior (HP:0000719) | 2.12490764 |
| 101 | Decreased circulating renin level (HP:0003351) | 2.11947728 |
| 102 | Abnormal ciliary motility (HP:0012262) | 2.11815709 |
| 103 | Hepatoblastoma (HP:0002884) | 2.11431058 |
| 104 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.10211113 |
| 105 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.10211113 |
| 106 | Abnormality of glycolipid metabolism (HP:0010969) | 2.10211113 |
| 107 | Keratoconjunctivitis sicca (HP:0001097) | 2.09743197 |
| 108 | Failure to thrive in infancy (HP:0001531) | 2.06476052 |
| 109 | Hemiparesis (HP:0001269) | 2.05371372 |
| 110 | Action tremor (HP:0002345) | 2.05035019 |
| 111 | Neuroendocrine neoplasm (HP:0100634) | 2.04634944 |
| 112 | Neurofibrillary tangles (HP:0002185) | 2.03504737 |
| 113 | Spastic gait (HP:0002064) | 2.02570932 |
| 114 | Disinhibition (HP:0000734) | 2.02256316 |
| 115 | Generalized hypopigmentation of hair (HP:0011358) | 2.01392510 |
| 116 | Congenital primary aphakia (HP:0007707) | 2.00926424 |
| 117 | Hyperthyroidism (HP:0000836) | 2.00322853 |
| 118 | Impaired smooth pursuit (HP:0007772) | 1.98719880 |
| 119 | Urticaria (HP:0001025) | 1.98632796 |
| 120 | Torticollis (HP:0000473) | 1.97829197 |
| 121 | Recurrent skin infections (HP:0001581) | 1.96937025 |
| 122 | Rhinitis (HP:0012384) | 1.95676235 |
| 123 | Lissencephaly (HP:0001339) | 1.95037448 |
| 124 | Muscle fiber splitting (HP:0003555) | 1.93769987 |
| 125 | Stereotypic behavior (HP:0000733) | 1.93605572 |
| 126 | Thyroid carcinoma (HP:0002890) | 1.92948008 |
| 127 | Keratoconjunctivitis (HP:0001096) | 1.90797599 |
| 128 | Prolonged bleeding time (HP:0003010) | 1.90615667 |
| 129 | Cholelithiasis (HP:0001081) | 1.90205357 |
| 130 | Nuclear cataract (HP:0100018) | 1.89739535 |
| 131 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.89622850 |
| 132 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.89622850 |
| 133 | Polycythemia (HP:0001901) | 1.89360829 |
| 134 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.89291677 |
| 135 | Hypoplasia of the brainstem (HP:0002365) | 1.89291677 |
| 136 | Abnormality of binocular vision (HP:0011514) | 1.86969450 |
| 137 | Diplopia (HP:0000651) | 1.86969450 |
| 138 | Infertility (HP:0000789) | 1.85997823 |
| 139 | Abnormal gallbladder morphology (HP:0012437) | 1.85853659 |
| 140 | Chronic bronchitis (HP:0004469) | 1.85812259 |
| 141 | Gingivitis (HP:0000230) | 1.84795624 |
| 142 | Nephrogenic diabetes insipidus (HP:0009806) | 1.83976842 |
| 143 | Open mouth (HP:0000194) | 1.83847901 |
| 144 | Labial hypoplasia (HP:0000066) | 1.82802117 |
| 145 | Abnormal EKG (HP:0003115) | 1.79937434 |
| 146 | Dysmetria (HP:0001310) | 1.79795363 |
| 147 | Leukocytosis (HP:0001974) | 1.79242991 |
| 148 | Generalized myoclonic seizures (HP:0002123) | 1.79115024 |
| 149 | Absent eyebrow (HP:0002223) | 1.78276847 |
| 150 | Dysdiadochokinesis (HP:0002075) | 1.77969610 |
| 151 | Widely spaced teeth (HP:0000687) | 1.77961622 |
| 152 | Sporadic (HP:0003745) | 1.77262998 |
| 153 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.76907439 |
| 154 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.76844359 |
| 155 | Abnormality of saccadic eye movements (HP:0000570) | 1.75775537 |
| 156 | Loss of speech (HP:0002371) | 1.75137558 |
| 157 | Autoamputation (HP:0001218) | 1.72917185 |
| 158 | Ocular albinism (HP:0001107) | 1.72262526 |
| 159 | Albinism (HP:0001022) | 1.71709815 |
| 160 | Iris hypopigmentation (HP:0007730) | 1.71416928 |
| 161 | Increased CSF protein (HP:0002922) | 1.69129870 |
| 162 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.68829755 |
| 163 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.68829755 |
| 164 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.68829755 |
| 165 | Pulmonary infiltrates (HP:0002113) | 1.67897799 |
| 166 | Neuronal loss in central nervous system (HP:0002529) | 1.67346914 |
| 167 | Osteomyelitis (HP:0002754) | 1.66858090 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 5.09160417 |
| 2 | NTRK3 | 4.06079924 |
| 3 | CASK | 3.97381320 |
| 4 | MAP3K4 | 3.25341027 |
| 5 | MAP2K7 | 2.98220326 |
| 6 | MAP3K9 | 2.94364331 |
| 7 | MAP3K12 | 2.53983326 |
| 8 | MAPK13 | 2.32427112 |
| 9 | EPHA4 | 2.28690400 |
| 10 | NTRK2 | 2.27869487 |
| 11 | MINK1 | 2.21108743 |
| 12 | PLK2 | 2.03865674 |
| 13 | BLK | 1.91765930 |
| 14 | LATS2 | 1.87855444 |
| 15 | MAP2K4 | 1.86357573 |
| 16 | IRAK4 | 1.75915799 |
| 17 | KSR1 | 1.75104575 |
| 18 | DAPK2 | 1.71066398 |
| 19 | PAK6 | 1.58874088 |
| 20 | GRK6 | 1.54751656 |
| 21 | TYK2 | 1.54175602 |
| 22 | DYRK2 | 1.53158618 |
| 23 | PRKD3 | 1.46535986 |
| 24 | MAP3K3 | 1.44310936 |
| 25 | SIK3 | 1.42151489 |
| 26 | MAP3K6 | 1.39385796 |
| 27 | MAP3K13 | 1.38359214 |
| 28 | GRK5 | 1.38041628 |
| 29 | DAPK1 | 1.37564523 |
| 30 | JAK1 | 1.37374667 |
| 31 | PHKG1 | 1.37362524 |
| 32 | PHKG2 | 1.37362524 |
| 33 | MAP2K3 | 1.36793216 |
| 34 | MUSK | 1.35072090 |
| 35 | PNCK | 1.32951321 |
| 36 | KSR2 | 1.27582390 |
| 37 | MAP3K1 | 1.26586633 |
| 38 | WNK1 | 1.25750763 |
| 39 | SIK2 | 1.25719253 |
| 40 | ERBB3 | 1.24280427 |
| 41 | CDK5 | 1.23828367 |
| 42 | PINK1 | 1.21293636 |
| 43 | NTRK1 | 1.20691013 |
| 44 | CSK | 1.19604019 |
| 45 | AKT3 | 1.18470986 |
| 46 | WNK3 | 1.17800570 |
| 47 | MAP3K2 | 1.15627201 |
| 48 | IKBKE | 1.14930912 |
| 49 | MAP3K11 | 1.13262315 |
| 50 | TNK2 | 1.13018165 |
| 51 | MARK3 | 1.09220635 |
| 52 | SYK | 1.07281171 |
| 53 | INSRR | 1.05494953 |
| 54 | PRKCG | 1.02034009 |
| 55 | CAMK2A | 1.00665589 |
| 56 | MAP4K1 | 0.99719991 |
| 57 | CSNK1G2 | 0.99501154 |
| 58 | TAOK3 | 0.96385825 |
| 59 | CCNB1 | 0.96172382 |
| 60 | BCR | 0.94020400 |
| 61 | MYLK | 0.93048399 |
| 62 | EPHA3 | 0.92976145 |
| 63 | ARAF | 0.90899800 |
| 64 | JAK2 | 0.90480042 |
| 65 | TXK | 0.89562566 |
| 66 | TAOK1 | 0.89276706 |
| 67 | TRPM7 | 0.88287602 |
| 68 | PAK3 | 0.88196185 |
| 69 | NLK | 0.88135346 |
| 70 | PRPF4B | 0.86250084 |
| 71 | UHMK1 | 0.84780077 |
| 72 | CDK18 | 0.84668827 |
| 73 | MARK2 | 0.84218482 |
| 74 | MOS | 0.81425694 |
| 75 | STK38 | 0.80986326 |
| 76 | EPHB1 | 0.80730343 |
| 77 | FRK | 0.79765953 |
| 78 | RET | 0.79559716 |
| 79 | TNIK | 0.79371370 |
| 80 | HCK | 0.77921717 |
| 81 | SGK2 | 0.77782072 |
| 82 | ERBB4 | 0.77768933 |
| 83 | CDK15 | 0.77005818 |
| 84 | PDK4 | 0.76304706 |
| 85 | PDK3 | 0.76304706 |
| 86 | CDK14 | 0.76219194 |
| 87 | BRAF | 0.74948876 |
| 88 | TGFBR2 | 0.74686031 |
| 89 | TAOK2 | 0.74261197 |
| 90 | YES1 | 0.73735002 |
| 91 | DYRK1A | 0.73030823 |
| 92 | ZAP70 | 0.72541829 |
| 93 | PRKCE | 0.72260257 |
| 94 | CDK19 | 0.72047597 |
| 95 | JAK3 | 0.71852011 |
| 96 | TEC | 0.71816937 |
| 97 | CAMK4 | 0.71190707 |
| 98 | SGK494 | 0.71130019 |
| 99 | SGK223 | 0.71130019 |
| 100 | RIPK4 | 0.69755720 |
| 101 | CAMKK1 | 0.69626268 |
| 102 | LYN | 0.66415631 |
| 103 | PDK1 | 0.64605826 |
| 104 | PTK2B | 0.63944312 |
| 105 | BMPR2 | 0.63658043 |
| 106 | CDK11A | 0.63640603 |
| 107 | SGK1 | 0.63576126 |
| 108 | HIPK2 | 0.62587705 |
| 109 | CAMK2B | 0.62307804 |
| 110 | ADRBK1 | 0.61390919 |
| 111 | TYRO3 | 0.60929693 |
| 112 | MAPK12 | 0.60227295 |
| 113 | CAMKK2 | 0.59185217 |
| 114 | RPS6KA2 | 0.59157506 |
| 115 | PIK3CG | 0.58708899 |
| 116 | STK11 | 0.58602204 |
| 117 | STK24 | 0.57900975 |
| 118 | RAF1 | 0.57885798 |
| 119 | DYRK3 | 0.54713328 |
| 120 | FES | 0.54498489 |
| 121 | IRAK2 | 0.54236234 |
| 122 | PRKCQ | 0.53456597 |
| 123 | MAPK7 | 0.52387932 |
| 124 | DMPK | 0.51895687 |
| 125 | NEK6 | 0.50859893 |
| 126 | PKN1 | 0.50843523 |
| 127 | FGR | 0.50088753 |
| 128 | PIM1 | 0.49181895 |
| 129 | MAP3K14 | 0.48571468 |
| 130 | STK4 | 0.47324107 |
| 131 | PRKCZ | 0.47169504 |
| 132 | CDK3 | 0.46172852 |
| 133 | CSNK1G3 | 0.45188747 |
| 134 | PRKCH | 0.44349637 |
| 135 | STK38L | 0.43481549 |
| 136 | PRKCI | 0.39817231 |
| 137 | RPS6KA3 | 0.36389460 |
| 138 | MAP3K5 | 0.34783301 |
| 139 | WNK4 | 0.33975610 |
| 140 | SGK3 | 0.32832824 |
| 141 | PRKAA1 | 0.32446528 |
| 142 | OXSR1 | 0.31867965 |
| 143 | PLK3 | 0.30916141 |
| 144 | PRKG1 | 0.30785615 |
| 145 | PRKCB | 0.29428175 |
| 146 | NME1 | 0.29255002 |
| 147 | CAMK1 | 0.28458599 |
| 148 | GRK7 | 0.28123364 |
| 149 | PRKACA | 0.28116441 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.85069598 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.21555736 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.70263113 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.54182251 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.48505516 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.45721939 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.45432622 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.41642947 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.27648479 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.27467211 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.20563549 |
| 12 | Insulin secretion_Homo sapiens_hsa04911 | 2.12240262 |
| 13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.07195045 |
| 14 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.98509812 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 1.97719250 |
| 16 | Cocaine addiction_Homo sapiens_hsa05030 | 1.88290691 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.84263783 |
| 18 | Malaria_Homo sapiens_hsa05144 | 1.83911775 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.75535195 |
| 20 | Renin secretion_Homo sapiens_hsa04924 | 1.72626961 |
| 21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.68391024 |
| 22 | Salivary secretion_Homo sapiens_hsa04970 | 1.67939817 |
| 23 | Long-term depression_Homo sapiens_hsa04730 | 1.66382543 |
| 24 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.61317645 |
| 25 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.60638416 |
| 26 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.49608468 |
| 27 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.48886154 |
| 28 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.47816570 |
| 29 | Axon guidance_Homo sapiens_hsa04360 | 1.44533840 |
| 30 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.44122966 |
| 31 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.39938634 |
| 32 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.38038816 |
| 33 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.36334919 |
| 34 | Gap junction_Homo sapiens_hsa04540 | 1.33322216 |
| 35 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.29832562 |
| 36 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.29723271 |
| 37 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.28657304 |
| 38 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.28336751 |
| 39 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.28265218 |
| 40 | Tuberculosis_Homo sapiens_hsa05152 | 1.23410623 |
| 41 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.19063914 |
| 42 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.17671769 |
| 43 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.17025097 |
| 44 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.14786854 |
| 45 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.12313347 |
| 46 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.10853414 |
| 47 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.10670155 |
| 48 | Leishmaniasis_Homo sapiens_hsa05140 | 1.10547655 |
| 49 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.07674496 |
| 50 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.05241675 |
| 51 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.02375573 |
| 52 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.01974930 |
| 53 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.99597405 |
| 54 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.99231691 |
| 55 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.98405946 |
| 56 | Glioma_Homo sapiens_hsa05214 | 0.96744972 |
| 57 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.96398288 |
| 58 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.94183126 |
| 59 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.93241386 |
| 60 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.93227690 |
| 61 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.92327102 |
| 62 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.91164919 |
| 63 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.89425358 |
| 64 | Melanogenesis_Homo sapiens_hsa04916 | 0.88975752 |
| 65 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.86560327 |
| 66 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85350305 |
| 67 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.84901981 |
| 68 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.82867689 |
| 69 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.81508849 |
| 70 | Phototransduction_Homo sapiens_hsa04744 | 0.81264568 |
| 71 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.81040184 |
| 72 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.79692477 |
| 73 | Measles_Homo sapiens_hsa05162 | 0.78673821 |
| 74 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.78349616 |
| 75 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.77431425 |
| 76 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.75143808 |
| 77 | Legionellosis_Homo sapiens_hsa05134 | 0.74553056 |
| 78 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73989333 |
| 79 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.72415429 |
| 80 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72055983 |
| 81 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.72003729 |
| 82 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71832945 |
| 83 | Alzheimers disease_Homo sapiens_hsa05010 | 0.71481628 |
| 84 | Pertussis_Homo sapiens_hsa05133 | 0.70736425 |
| 85 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.68957577 |
| 86 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.68915370 |
| 87 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.67273721 |
| 88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66662646 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65949013 |
| 90 | Circadian rhythm_Homo sapiens_hsa04710 | 0.65497057 |
| 91 | Platelet activation_Homo sapiens_hsa04611 | 0.64754745 |
| 92 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.64248219 |
| 93 | Colorectal cancer_Homo sapiens_hsa05210 | 0.64092562 |
| 94 | Endometrial cancer_Homo sapiens_hsa05213 | 0.63101660 |
| 95 | Hepatitis B_Homo sapiens_hsa05161 | 0.62896800 |
| 96 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.62860732 |
| 97 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.62820018 |
| 98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.62465904 |
| 99 | Amoebiasis_Homo sapiens_hsa05146 | 0.60762544 |
| 100 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.59161893 |
| 101 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.58926335 |
| 102 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.58861202 |
| 103 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58318667 |
| 104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58242563 |
| 105 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.56541418 |
| 106 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.55898682 |
| 107 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.55355743 |
| 108 | Lysosome_Homo sapiens_hsa04142 | 0.54965577 |
| 109 | Salmonella infection_Homo sapiens_hsa05132 | 0.54601381 |
| 110 | Alcoholism_Homo sapiens_hsa05034 | 0.54572018 |
| 111 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53994639 |
| 112 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.53289857 |
| 113 | Phagosome_Homo sapiens_hsa04145 | 0.52406731 |
| 114 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.52082617 |
| 115 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.50919414 |
| 116 | Huntingtons disease_Homo sapiens_hsa05016 | 0.50712904 |
| 117 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50577255 |
| 118 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.50057547 |
| 119 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49370741 |
| 120 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49144063 |
| 121 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48036772 |
| 122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47725564 |
| 123 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.47305941 |
| 124 | Parkinsons disease_Homo sapiens_hsa05012 | 0.44540666 |
| 125 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.44422400 |
| 126 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44176887 |
| 127 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.41233792 |
| 128 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38788969 |
| 129 | Prion diseases_Homo sapiens_hsa05020 | 0.37894751 |
| 130 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.36754224 |
| 131 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.36327627 |
| 132 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35245386 |
| 133 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.33423104 |
| 134 | Endocytosis_Homo sapiens_hsa04144 | 0.31006136 |
| 135 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.26512837 |

